Skip to main content
. 2021 Mar 24;10(7):e018696. doi: 10.1161/JAHA.120.018696

Figure 1. Summary of quality measures across regions including completion of composite achievement measures and inpatient mortality.

Figure 1

Left panel: percentage of regional completion of the composite achievement measure. Composite achievement measure included a composite of prescription of evidenced‐based ACEI/ARB or ARB–neprilysin inhibitor and beta‐blocker, documentation of a postdischarge appointment and measurement of left ventricular function. Right panel: adjusted odds ratios and 95% CI for inpatient mortality by region (reference=Northeast region). ACEI indicates angiotension‐converting enzyme inhibitor; and ARB, angiotensin receptor blocker.